𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Studies on the insulin-antagonistic effect of catecholamines in normal man

✍ Scribed by I. Lager; S. Attvall; B. M. Eriksson; H. von Schenk; U. Smith


Publisher
Springer
Year
1986
Tongue
English
Weight
889 KB
Volume
29
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

✦ Synopsis


The insulin-antagonistic effect of adrenaline was studied in seven healthy subjects with the euglycaemic clamp technique using two insulin infusion rates (40 and 1200 mU. (m 2)-l min-1). The adrenergic receptor mediating the adrenaline effect was characterized by concomitant infusion of propranolol (j31 +fl2-antagonist) or metoprolol (ill-antagonist). Each subject was studied four times (placebo, adrenaline, adrenaline + propranolol, adrenaline + metoprolol). Glucose turnover was measured with D(3-3H)-glucose. Similar plasma insulin levels were reached in all studies with the two insulin infusion rates (mean; placebo 51 _+ 3 and 7421 +_ 337 mU/l respectively). Glucose production was completely inhibited by the low insulin level during placebo infusion. Adrenaline antagonized this effect so that a significant glucose production was seen at the low but not at the high insulin level. Proprano-1ol, but not metoprolol, reversed this insulin-antagonistic ef-feet of adrenaline. Glucose utilization increased from 2.53 _+ 0.17 to 7.28 _+ 0.88 mg. kg -1. rain -~ during placebo when the insulin levels were increased from 4 + 0.3 to 51 _+ 3 mU/1. Increasing the insulin levels 150-fold to ~7500 mU/1 only doubled the glucose utilization (14.68 + 1.14 mg. kg -1. min-l). Adrenaline induced a pronounced inhibition of glucose utilization at both insulin levels (78% and 37% inhibition respectively). Propranolol, but not metoprolol, prevented this effect of adrenaline. Thus, physiological adrenaline levels exert a pronounced insulin-antagonistic effect which is mediated by fl2-receptor stimulation. The inhibitory effect on glucose uptake is maintained even at high insulin levels when hepatic glucose production is completely abolished.


πŸ“œ SIMILAR VOLUMES


Characterization of the insulin-antagoni
✍ J. Fowelin; S. Attvall; H. von Schenck; U. Smith; I. Lager πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 666 KB

The insulin-antagonistic effect of growth hormone was characterized by infusing the hormone at three different infusion rates (6, 12 or 24mU.kg-\*.min -1) for one h in 11 healthy subjects. The insulin effect was measured with the euglycaemic clamp technique combined with D-(3-3H)-glucose infusion to

The effects of insulin-induced hypoglyca
✍ B. M. Fisher; G. Gillen; H. J. Dargie; G. C. Inglis; B. M. Frier πŸ“‚ Article πŸ“… 1987 πŸ› Springer 🌐 English βš– 481 KB

The cardiovascular effects of an intravenous injection of soluble insulin and of acute hypoglycaemia were examined in six normal male subjects using multiple-gated radionuclide ventriculography. The basal left ventricular ejection fraction rose significantly from 47 +/- 3% (mean +/- SEM) to 54 +/- 3

Effect of insulin on ketone body clearan
✍ U. Keller; M. Lustenberger; W. Stauffacher πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 714 KB

The effect of elevated plasma insulin concentration (55 +/- 2 mU/l) on peripheral clearance and production of total ketone bodies was determined using 3-14C-acetoacetate tracer infusions. Nine normal subjects were studied twice, once during insulin infusion (20 mU.m-2.min-1), once during basal plasm